Amelioration of small bowel injury by switching from nonselective nonsteroidal anti-inflammatory drugs to celecoxib in rheumatoid arthritis patients: A pilot study

Digestion

Volumn 89, Issue 2, 2014, Pages 124-132

  Inoue, Takahiro ^a   Iijima, Hideki ^a   Arimitsu, Junsuke ^a   Hagihara, Keisuke ^a   Kawai, Shoichiro ^a   Shiraishi, Eri ^a   Hiyama, Satoshi ^a   Mukai, Akira ^c   Shinzaki, Shinichiro ^a   Nishida, Tsutomu ^a   Ogata, Atsushi ^a,b   Tsujii, Masahiko ^a   Takehara, Tetsuo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c SUMITOMO HOSPITAL   (Japan)

Author keywords

Cyclooxygenase 2 selective inhibitor; Nonsteroidal anti inflammatory drugs; Small bowel injury; Video capsule endoscopy

Indexed keywords

BUCILLAMINE; CELECOXIB; CORTICOSTEROID; DICLOFENAC; HISTAMINE H2 RECEPTOR ANTAGONIST; INDOMETACIN; LOXOPROFEN; METHOTREXATE; PROTON PUMP INHIBITOR; SALAZOSULFAPYRIDINE; CYTOKINE;

ADULT; ARTICLE; CAPSULE ENDOSCOPY; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG SUBSTITUTION; FEMALE; HUMAN; INTESTINE INJURY; MALE; MIDDLE AGED; OPEN STUDY; PETECHIA; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; VIDEO CAPSULE ENDOSCOPY; CONTROLLED STUDY; DRUG WITHDRAWAL; GASTROENTEROLOGIST; SINGLE BLIND PROCEDURE; SMALL INTESTINE;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; CAPSULE ENDOSCOPY; CYTOKINES; DICLOFENAC; DRUG SUBSTITUTION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; INDOMETHACIN; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MIDDLE AGED; PHENYLPROPIONATES; PILOT PROJECTS; PROSPECTIVE STUDIES; PYRAZOLES; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; SULFONAMIDES;

EID: 84893700302     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000357229     Document Type: Article

References (45)

1. Feely MG, Erickson A, O'Dell JR: Therapeutic options for rheumatoid arthritis. Expert Opin Pharmacother 2009; 10:2095-2106.
2. Laine L: Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology 2001; 120:594-606.
3. Gabriel SE, Jaakkimainen L, Bombardier C: Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991; 115:787-796.
4. Singh G, Rosen Ramey D: NSAID induced gastrointestinal complications: the ARAMIS perspective-1997. Arthritis, Rheumatism, and Aging Medical Information System. J Rheumatol Suppl 1998; 51:8-16.
5. Blower AL, Brooks A, Fenn GC, Hill A, Pearce MY, Morant S, Bardhan KD: Emergency admissions for upper gastrointestinal disease and their relation to NSAID use. Aliment Pharmacol Ther 1997; 11:283-291.
6. Laine L, Connors LG, Reicin A, Hawkey CJ, Burgos-Vargas R, Schnitzer TJ, Yu Q, Bombardier C: Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. Gastroenterology 2003; 124:288-292.
7. Morris AJ, Wasson LA, MacKenzie JF: Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut 1992; 33:887-889.
8. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB: Arachidonic acid metabolism. Annu Rev Biochem 1986; 55:69-102.
9. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971; 231:232-235.
10. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR: TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991; 266:12866-12872.
11. Masferrer JL, Zweifel BS, Manning PT, Haus-er SD, Leahy KM, Smith WG, Isakson PC, Seibert K: Selective inhibition of inducible cy-clooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 1994; 91:3228-3232.
12. Emery P, Zeidler H, Kvien TK, Guslandi M, Naudin R, Stead H, Verburg KM, Isakson PC, Hubbard RC, Geis GS: Celecoxib versus di-clofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet 1999; 354:2106-2111.
13. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS: Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000; 284: 1247-1255.
14. Simon LS, Weaver AL, Graham DY, Kivitz AJ, Lipsky PE, Hubbard RC, Isakson PC, Verburg KM, Yu SS, Zhao WW, Geis GS: Anti-inflammatory and upper gastrointestinal effects of ce-lecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA 1999; 282:1921-1928.
15. Rostom A, Muir K, Dubé C, Jolicoeur E, Boucher M, Joyce J, Tugwell P, Wells GW: Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review. Clin Gastroenterol Hepatol 2007; 5:818-828.
16. Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG: Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 2005; 3:133-141.
17. Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Aisenberg J, Bhadra P, Berger MF: Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Aliment Pharmacol Ther 2007; 25:1211-1222.
18. Meron GD: The development of the swallow-able video capsule (M2A). Gastrointest En-dosc 2000; 52:817-819.
19. Iddan G, Meron G, Glukhovsky A, Swain P: Wireless capsule endoscopy. Nature 2000; 405: 417.
20. Sugimori S, Watanabe T, Tabuchi M, Kameda N, Machida H, Okazaki H, Tanigawa T, Ya-magami H, Shiba M, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, Koike T, Higuchi K, Arakawa T: Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs. Digestion 2008; 78:208-213.
21. Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I: A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology 2005; 128:1172-1178.
22. Gralnek IM, Defranchis R, Seidman E, Leigh-ton JA, Legnani P, Lewis BS: Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther 2008; 27:146-154.
23. Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N: Comparison of Disease Activity Score (DAS)28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values. Ann Rheum Dis 2007; 66:407-409.
24. Mizukami K, Murakami K, Yamauchi M, Matsunari O, Ogawa R, Nakagawa Y, Okimo-to T, Kodama M, Fujioka T: Evaluation of selective cyclooxygenase-2 inhibitor-induced small bowel injury: randomized cross-over study compared with loxoprofen in healthy subjects. Dig Endosc 2013; 25:288-294.
25. Chan FK, Lanas A, Scheiman J, Berger MF, Nguyen H, Goldstein JL: Celecoxib versus ome-prazole and diclofenac in patients with osteoar-thritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet 2010; 376: 173-179.
26. Hitchon CA, Alex P, Erdile LB, Frank MB, Dozmorov I, Tang Y, Wong K, Centola M, El-Gabalawy HS: A distinct multicytokine profile is associated with anti-cyclical citrullinat-ed peptide antibodies in patients with early untreated inflammatory arthritis. J Rheuma-tol 2004; 31:2336-2346.
27. Meyer PW, Hodkinson B, Ally M, Musenge E, Wadee AA, Fickl H, Tikly M, Anderson R: Circulating cytokine profiles and their relationships with autoantibodies, acute phase re-actants, and disease activity in patients with rheumatoid arthritis. Mediators Inflamm 2010; 2010:158514.
28. Alex P, Szodoray P, Knowlton N, Dozmorov IM, Turner M, Frank MB, Arthur RE, Willis L, Flinn D, Hynd RF, Carson C, Kumar A, El-Ga-balawy HS, Centola M: Multiplex serum cyto-kine monitoring as a prognostic tool in rheumatoid arthritis. Clin Exp Rheumatol 2007; 25: 584-592.
29. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rach-milewitz D, Wolf DC, Olson A, Bao W, Rut-geerts P, Group AIS: Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002; 359:1541-1549.
30. Ito H, Takazoe M, Fukuda Y, Hibi T, Kusu-gami K, Andoh A, Matsumoto T, Yamamura T, Azuma J, Nishimoto N, Yoshizaki K, Shi-moyama T, Kishimoto T: A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 2004; 126: 989-996.
31. Watanabe T, Tanigawa T, Shiba M, Nadatani Y, Nagami Y, Sugimori S, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y, Koike T, Arakawa T: Anti-tumour necrosis factor agents reduce non-steroidal anti-inflammatory drug-induced small bowel injury in rheumatoid arthritis patients. Gut DOI: 10.1136/gutjnl-2013- 304713.
32. Cury DH, Costa JE, Irika K, Mijji L, Garcez A, Buchiguel C, Silva I, Sipahi A: Protective effect of octreotide and infliximab in an experimental model of indomethacin-induced inflammatory bowel disease. Dig Dis Sci 2008; 53:2516-2520.
33. Niwa Y, Nakamura M, Ohmiya N, Maeda O, Ando T, Itoh A, Hirooka Y, Goto H: Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study. J Gas-troenterol 2008; 43:270-276.
34. Fujimori S, Seo T, Gudis K, Ehara A, Kobayas-hi T, Mitsui K, Yonezawa M, Tanaka S, Tatsu-guchi A, Sakamoto C: Prevention of nonste-roidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy. Gastrointest Endosc 2009; 69: 1339-1346.
35. Niwa Y, Nakamura M, Miyahara R, Ohmiya N, Watanabe O, Ando T, Kawashima H, Itoh A, Hirooka Y, Goto H: Geranylgeranylace-tone protects against diclofenac-induced gastric and small intestinal mucosal injuries in healthy subjects: a prospective randomized placebo-controlled double-blind cross-over study. Digestion 2009; 80:260-266.
36. Kuramoto T, Umegaki E, Nouda S, Nara-bayashi K, Kojima Y, Yoda Y, Ishida K, Kawakami K, Abe Y, Takeuchi T, Inoue T, Murano M, Tokioka S, Higuchi K: Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study. BMC Gastroenterol 2013; 13:85.
37. Higuchi K, Yoda Y, Amagase K, Kato S, To-kioka S, Murano M, Takeuchi K, Umegaki E: Prevention of NSAID-induced small intestinal mucosal injury: prophylactic potential of lansoprazole. J Clin Biochem Nutr 2009; 45: 125-130.
38. Yoda Y, Amagase K, Kato S, Tokioka S, Mu-rano M, Kakimoto K, Nishio H, Umegaki E, Takeuchi K, Higuchi K: Prevention by lanso-prazole, a proton pump inhibitor, of indo-methacin-induced small intestinal ulceration in rats through induction of heme oxygen-ase-1. J Physiol Pharmacol 2010; 61:287-294.
39. Wallace JL, Syer S, Denou E, de Palma G, Vong L, McKnight W, Jury J, Bolla M, Bercik P, Collins SM, Verdu E, Ongini E: Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology 2011; 141:1314-1322.
40. Satoh H, Amagase K, Takeuchi K: Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecre-tory drugs in rats: the role of intestinal motil-ity. J Pharmacol Exp Ther 2012; 343:270-277.
41. Lim YJ, Phan TM, Dial EJ, Graham DY, Lich-tenberger LM: In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phos-phatidylcholine. Digestion 2012; 86:171-177.
42. Wallace JL: Glucocorticoid-induced gastric mucosal damage: inhibition of leukotriene, but not prostaglandin biosynthesis. Prosta-glandins 1987; 34:311-323.
43. Nobuhara Y, Ueki S, Takeuchi K: Influence of prednisolone on gastric alkaline response in rat stomach. A possible explanation for steroid-induced gastric lesion. Dig Dis Sci 1985; 30:1166-1173.
44. Filaretova LP, Filaretov AA, Makara GB: Cor-ticosterone increase inhibits stress-induced gastric erosions in rats. Am J Physiol 1998; 274:G1024-G1030.
45. Filaretova L, Podvigina T, Bagaeva T, Makara G: Gastroprotective action of glucocorticoids during the formation and the healing of indo-methacin-induced gastric erosions in rats. J Physiol Paris 2001; 95:201-208.